Abstract
Protein-protein interactions (PPIs) play a key role in many cellular processes. Uncovering the PPIs and their function within the cell is a challenge of post-genomic biology and will improve our understanding of disease and help in the development of novel methods for disease diagnosis and forensics. The experimental methods currently used to identify PPIs are both time-consuming and expensive, and high throughput experimental results have shown both high false positive beside false negative information for protein interaction. These obstacles could be overcome by developing computational approaches to predict PPIs and validate the obtained experimental results. In this work, we will describe the recent advances in predicting protein-protein interaction from the following aspects: i) the benchmark dataset construction, ii) the sequence representation approaches, iii) the common machine learning algorithms, and iv) the cross-validation test methods and assessment metrics.
Keywords: Protein-protein interaction, prediction, dataset construction, sequence representation, machine learning, crossvalidation test.
Medicinal Chemistry
Title:Some Remarks on Prediction of Protein-Protein Interaction with Machine Learning
Volume: 11 Issue: 3
Author(s): Shao-Wu Zhang and Ze-Gang Wei
Affiliation:
Keywords: Protein-protein interaction, prediction, dataset construction, sequence representation, machine learning, crossvalidation test.
Abstract: Protein-protein interactions (PPIs) play a key role in many cellular processes. Uncovering the PPIs and their function within the cell is a challenge of post-genomic biology and will improve our understanding of disease and help in the development of novel methods for disease diagnosis and forensics. The experimental methods currently used to identify PPIs are both time-consuming and expensive, and high throughput experimental results have shown both high false positive beside false negative information for protein interaction. These obstacles could be overcome by developing computational approaches to predict PPIs and validate the obtained experimental results. In this work, we will describe the recent advances in predicting protein-protein interaction from the following aspects: i) the benchmark dataset construction, ii) the sequence representation approaches, iii) the common machine learning algorithms, and iv) the cross-validation test methods and assessment metrics.
Export Options
About this article
Cite this article as:
Zhang Shao-Wu and Wei Ze-Gang, Some Remarks on Prediction of Protein-Protein Interaction with Machine Learning, Medicinal Chemistry 2015; 11 (3) . https://dx.doi.org/10.2174/1573406411666141230095838
DOI https://dx.doi.org/10.2174/1573406411666141230095838 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Gene Therapy Strategies for Colorectal Cancer
Current Genomics Meet Our Editorial Board Member:
Current Drug Targets Painting the Target Around the Arrow: Two-Step Prodrug Therapies from a Carbohydrate Chemists Perspective
Current Drug Delivery Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Current Pharmaceutical Design Editorial (Thematic Issue: Signalling Pathways in Anti-cancer Drug Resistance)
Current Medicinal Chemistry The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer
Current Drug Targets The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH<sub>2</sub>Ph)]Br
Anti-Cancer Agents in Medicinal Chemistry Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Current Pharmaceutical Design Anti-apoptotic Serpins as Therapeutics in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Extraction of Triacylglycerols and Fatty Acids Using Supercritical Fluids - Review
Current Analytical Chemistry Subject Index to Volume 10
Current Medicinal Chemistry Aptamers: Potential Applications to Pancreatic Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects
Current Bioactive Compounds Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry Insights into the Pathogenesis and Intervention of Atherosclerosis
Vascular Disease Prevention (Discontinued) Lapatinib as a Chemotherapeutic Drug
Recent Patents on Anti-Cancer Drug Discovery Prostate Cancer Molecular Background: The IGF-1Ec Story
Clinical Cancer Drugs Mucosal Healing in Crohn’s Disease: Relevance for Clinical Outcomes
Current Drug Targets